tiprankstipranks
Advertisement
Advertisement

AU:LDX Stock Latest News

Lumos Diagnostics Launches A$20m Equity Raising via Placement and SPP
Company AnnouncementsLumos Diagnostics Launches A$20m Equity Raising via Placement and SPP
1d ago
LDX
Lumos Diagnostics Wins Key U.S. Clearance as FebriDx Drives Strong Quarterly Growth
PremiumCompany Announcements
Lumos Diagnostics Wins Key U.S. Clearance as FebriDx Drives Strong Quarterly Growth
2d ago
LDX
Lumos Diagnostics Announces Lapse of Performance Rights and Options
PremiumCompany Announcements
Lumos Diagnostics Announces Lapse of Performance Rights and Options
6d ago
LDX
Lumos Diagnostics Sets Q3 FY26 Results Date and Reminds Investors of Share Purchase Plan
PremiumCompany Announcements
Lumos Diagnostics Sets Q3 FY26 Results Date and Reminds Investors of Share Purchase Plan
7d ago
LDX
Lumos Diagnostics Widens FebriDx Rollout Across WellStreet Urgent Care Network
PremiumCompany Announcements
Lumos Diagnostics Widens FebriDx Rollout Across WellStreet Urgent Care Network
8d ago
LDX
Lumos Banks US$5 Million FebriDx Milestone as CLIA Waiver Unlocks U.S. Market
PremiumCompany AnnouncementsLumos Banks US$5 Million FebriDx Milestone as CLIA Waiver Unlocks U.S. Market
8d ago
LDX
Lumos Explains Timing of Market Update on FebriDx FDA Clearance and CLIA Waiver
Premium
Company Announcements
Lumos Explains Timing of Market Update on FebriDx FDA Clearance and CLIA Waiver
12d ago
LDX
Lumos Diagnostics Launches A$2m Share Purchase Plan With Attaching Options
Premium
Company Announcements
Lumos Diagnostics Launches A$2m Share Purchase Plan With Attaching Options
12d ago
LDX
Lumos Diagnostics launches A$2m share purchase plan for eligible investors
PremiumCompany Announcements
Lumos Diagnostics launches A$2m share purchase plan for eligible investors
12d ago
LDX
Lumos Diagnostics Seeks ASX Quotation for 31 Million New Shares
PremiumCompany Announcements
Lumos Diagnostics Seeks ASX Quotation for 31 Million New Shares
13d ago
LDX
Lumos Diagnostics Issues 31 Million New Shares on Option Exercise
PremiumCompany Announcements
Lumos Diagnostics Issues 31 Million New Shares on Option Exercise
13d ago
LDX
Lumos Diagnostics Seeks ASX Quotation for 88.9 Million New Shares
PremiumCompany Announcements
Lumos Diagnostics Seeks ASX Quotation for 88.9 Million New Shares
13d ago
LDX
Lumos Diagnostics Issues 88.9 Million New Shares Under Cleansing Notice
PremiumCompany AnnouncementsLumos Diagnostics Issues 88.9 Million New Shares Under Cleansing Notice
13d ago
LDX
Lumos Wins Three-Year Manufacturing Deal for Micro-Pak Mold Analyzer
Premium
Company Announcements
Lumos Wins Three-Year Manufacturing Deal for Micro-Pak Mold Analyzer
14d ago
LDX
Lumos Issues 5 Million New Shares on Option Exercise, Confirms Regulatory Compliance
Premium
Company Announcements
Lumos Issues 5 Million New Shares on Option Exercise, Confirms Regulatory Compliance
20d ago
LDX
Lumos Diagnostics Seeks Quotation for 5 Million New ASX Shares
PremiumCompany Announcements
Lumos Diagnostics Seeks Quotation for 5 Million New ASX Shares
20d ago
LDX
Lumos Diagnostics to Brief Investors on FebriDx Clearance and Capital Raising
PremiumCompany Announcements
Lumos Diagnostics to Brief Investors on FebriDx Clearance and Capital Raising
26d ago
LDX
Lumos Diagnostics Launches A$20 Million Capital Raising via Placement and SPP
PremiumCompany Announcements
Lumos Diagnostics Launches A$20 Million Capital Raising via Placement and SPP
26d ago
LDX
Lumos Diagnostics Launches Securities Purchase Plan to Issue New Shares and Options
PremiumCompany Announcements
Lumos Diagnostics Launches Securities Purchase Plan to Issue New Shares and Options
26d ago
LDX
Lumos Diagnostics Plans Major Share and Options Issue on ASX
PremiumCompany AnnouncementsLumos Diagnostics Plans Major Share and Options Issue on ASX
26d ago
LDX
Lumos raises capital to accelerate U.S. rollout of FebriDx after CLIA waiver
Premium
Company Announcements
Lumos raises capital to accelerate U.S. rollout of FebriDx after CLIA waiver
26d ago
LDX
Lumos Wins FDA CLIA Waiver for FebriDx, Unlocking US$1 Billion Market
Premium
Company Announcements
Lumos Wins FDA CLIA Waiver for FebriDx, Unlocking US$1 Billion Market
26d ago
LDX

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >